| |
Control group
|
Pregnant group
|
p value
|
|---|
|
Mean + SE (µm)
|
Mean + SE (µm)
|
|---|
|
T5
|
277.4 + 9.6
|
278.5 + 13.9
|
0.949
|
|
T4
|
284.8 + 10.1
|
291.5 + 15.2
|
0.716
|
|
T3
|
292.1 + 9.8
|
300.9 + 14.3
|
0.611
|
|
T2
|
301.7 + 8.9
|
308.2 + 14.8
|
0.708
|
|
T1
|
299.1 + 8.6
|
311.2 + 14.8
|
0.478
|
|
SF
|
304.1 + 9.6
|
318.1 + 15.6
|
0.446
|
|
N1
|
285.1 + 9.6
|
291.3 + 14.9
|
0.730
|
|
N2
|
270.3 + 10.6
|
267.1 + 14.7
|
0.860
|
|
N3
|
245.6 + 10.9
|
239.4 + 13.9
|
0.725
|
|
N4
|
213.5 + 11.5
|
210.2 + 12.2
|
0.843
|
- GEE with Bonferroni adjustment
- T5: choroidal thickness at 2500 µm temporally to the fovea; T4: choroidal thickness at 2000 µm temporally to the fovea; T3: choroidal thickness at 1500 µm temporally to the fovea; T2: choroidal thickness at 1000 µm temporally to the fovea; T1: choroidal thickness at 500 µm temporally to the fovea; SF: choroidal thickness at the fovea; N1: choroidal thickness at 500 µm nasally to the fovea; N2: choroidal thickness at 1000 µm nasally to the fovea; N3: choroidal thickness at 1500 µm nasally to the fovea; N4: choroidal thickness at 2000 µm nasally to the fovea